Research and Markets: Global Nuclear Medicine Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 - 2015)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a818ea/global_nuclear_med) has announced the addition of the "Global Nuclear Medicine Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 - 2015)" report to their offering.

“Global Nuclear Medicine Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 - 2015)”

Radiopharmaceuticals Therapy and PET/SPECT Imaging - A Global Scenario (2010-2015)

Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930's. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceuticals market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1% from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market.

This research report categorizes the radiopharmaceuticals therapy and PET/SPECT imaging market on the basis of isotopes, routes of administration, applications, and geography; forecasting revenue, and analyzing trends in each of the following submarkets:

On the basis of isotopes:

Fludeoxyglucose (F18), Technetium (Tc99m), Gallium (Ga67), Sodium Iodide (I123), Iobenguane (I131), Rhenium (Re186), Samarium (Sm153),Thallium (Tl201), Yttrium (Y90), Erbium(Er169), and others

On the basis of routes of administration:

• Intravenous, peroral, inhalation, and others

On the basis of applications:

• Diagnosis (PET and SPECT), indication for diagnosis, and therapy

On the basis of geography:

• North America (U.S. and Canada), Europe, Asia-Pacific, Japan, and Rest of the World

Companies Mentioned:

• Australian Nuclear Association And Technology Organization (Ansto)
• Board Of Radiation And Isotope Technology (Brit)
• Cardinal Health Inc
• Covidien Plc
• Eczacibasi-Monrol
• Fujifilm Holdings Corp
• Ge Healthcare
• Iba Group
• Institute Of Atomic Energy Polatom Radioisotope Centre (Polatom)
• Institute Of Isotopes Co. Ltd.
• Institute Of Radioelement (Ire)
• Lantheus Medical Imaging Inc
• Nordion Inc
• Ntp Radioisotopes (Pty) Ltd
• Samyoung Unitech Co. Ltd
• Siemens Healthcare

For more information visit http://www.researchandmarkets.com/research/a818ea/global_nuclear_med